Department of Psychology, University of Southern California, Los Angeles, CA 90089-1061, USA.
Psychooncology. 2013 Jun;22(6):1396-401. doi: 10.1002/pon.3155. Epub 2012 Aug 13.
For many patients with lung cancer, disease progression occurs without notice or with vague symptoms, and unfortunately, most treatments are not curative. Given this unpredictability, we hypothesized the following: (1) poorer psychological adjustment (specifically, more depressive symptoms, higher perceptions of stress, and poorer emotional well-being) would be associated with higher intolerance for uncertainty, higher perceived illness-related ambiguity, and their interaction; and (2) greater avoidance would mediate associations between higher intolerance of uncertainty and poorer psychological adjustment.
Participants (N = 49) diagnosed with lung cancer at least 6 months prior to enrollment completed the Center for Epidemiologic Studies - Depression Scale, the Functional Assessment of Cancer Therapy - Lung Emotional Well-being subscale, the Perceived Stress scale, the Intolerance of Uncertainty scale, the Mishel Uncertainty in Illness Scale Ambiguity subscale, the Impact of Event - Revised Avoidance subscale, and the Short-scale Eysenck Personality Questionnaire - Revised Neuroticism subscale. Mean age was 64.2 years (standard deviation [SD] = 11.0), mean years of education was 15.6 (SD = 3.1), and 71.4% were female. Hypotheses were tested with regression analyses, adjusted for neuroticism.
Higher perceptions of stress and poorer emotional well-being were associated with higher levels of intolerance of uncertainty and higher perceived illness-related ambiguity. Non-somatic depressive symptoms were associated with higher levels of intolerance of uncertainty. Avoidance was found to mediate relations of intolerance of uncertainty with non-somatic depressive symptoms and emotional well-being only.
Findings suggest that interventions to address avoidance and intolerance of uncertainty in individuals with lung cancer may help improve psychological adjustment.
对于许多肺癌患者来说,疾病的进展没有任何迹象或症状不明显,不幸的是,大多数治疗方法都无法治愈。鉴于这种不可预测性,我们假设以下内容:(1)较差的心理调整(特别是更多的抑郁症状、更高的压力感知和较差的情绪健康)将与更高的不确定性容忍度、更高的疾病相关的不确定性感知和它们的相互作用相关;(2)更大的回避将介导不确定性容忍度较高与较差的心理调整之间的关联。
参与者(N = 49)在登记前至少 6 个月被诊断患有肺癌,完成了流行病学研究中心抑郁量表、癌症治疗功能评估-肺情绪健康子量表、压力感知量表、不确定性容忍度量表、米舍尔疾病不确定性量表不明确子量表、事件影响修订版回避子量表和短量表艾森克人格问卷修订版神经质子量表。平均年龄为 64.2 岁(标准差[SD] = 11.0),平均受教育年限为 15.6 年(SD = 3.1),71.4%为女性。假设通过回归分析进行测试,调整了神经质。
较高的压力感知和较差的情绪健康与较高的不确定性容忍度和较高的疾病相关不确定性感知有关。非躯体性抑郁症状与不确定性容忍度较高有关。回避被发现仅在不确定性容忍度与非躯体性抑郁症状和情绪健康之间的关系中起中介作用。
研究结果表明,针对肺癌患者回避和不确定性容忍度的干预措施可能有助于改善心理调整。